Dr. James H. Cook received his medical degree at Medical College of Pennsylvania (now Drexel University College of Medicine), and completed an internal medicine internship at Albert Einstein Medical Center and a Neurology residency at Temple University Hospital, both in Philadelphia. He completed a fellowship in Movement Disorders at Yale University School of Medicine in New Haven, CT.
He is board certified in Neurology by the American Board of Psychiatry and Neurology, and is a member of the Movement Disorder Society and the American Academy of Neurology.
Abington Neurological Associates
Since 2001, Dr. Cook has been a partner at Abington Neurological Associates, one of the largest private neurology practices in Montgomery and Bucks County. ANA has provided high quality comprehensive neurological care to the community for over 50 years.
While various opinions are circulating, and the benefits of this drug are unclear, ANA will continue to monitor the situation and provide updates as information becomes available.
It was once so common to be forgetful in old age that it was thought to be normal. But normal aging only includes things like tip-of-tongue memory loss and forgetting faces.
In the narrow window in which patients are aware of their disease, they have sought help in clinical trials. But enrolling enough participants to make these trials count is not easy.
In patients with early Alzheimer’s disease, donanemab resulted in a better composite score for cognition and for the ability to perform activities of daily living than placebo at 76 weeks, although results for secondary outcomes were mixed.
